Your browser doesn't support javascript.
loading
TSH and FT4 Reference Interval Recommendations and Prevalence of Gestational Thyroid Dysfunction: Quantification of Current Diagnostic Approaches.
Osinga, Joris A J; Derakhshan, Arash; Feldt-Rasmussen, Ulla; Huang, Kun; Vrijkotte, Tanja G M; Männistö, Tuija; Bassols, Judit; López-Bermejo, Abel; Aminorroaya, Ashraf; Vafeiadi, Marina; Broeren, Maarten A C; Palomaki, Glenn E; Ashoor, Ghalia; Chen, Liangmiao; Lu, Xuemian; Taylor, Peter N; Tao, Fang-Biao; Brown, Suzanne J; Sitoris, Georgiana; Chatzi, Lida; Vaidya, Bijay; Popova, Polina V; Vasukova, Elena A; Kianpour, Maryam; Suvanto, Eila; Grineva, Elena N; Hattersley, Andrew; Pop, Victor J M; Nelson, Scott M; Walsh, John P; Nicolaides, Kypros H; D'Alton, Mary E; Poppe, Kris G; Chaker, Layal; Bliddal, Sofie; Korevaar, Tim I M.
Afiliación
  • Osinga JAJ; Department of Internal Medicine, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Derakhshan A; Academic Center for Thyroid Diseases, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Feldt-Rasmussen U; Department of Internal Medicine, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Huang K; Academic Center for Thyroid Diseases, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
  • Vrijkotte TGM; Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
  • Männistö T; Department of Clinical Medicine, Faculty of Health and clinical Sciences, Copenhagen University, 1172 Copenhagen, Denmark.
  • Bassols J; Department of Maternal, Child and Adolescent Health, Scientific Research Center in Preventive Medicine, School of Public Health, Anhui Medical University, 230032 Anhui, China.
  • López-Bermejo A; Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, 1081 HV Amsterdam, The Netherlands.
  • Aminorroaya A; Northern Finland Laboratory Center Nordlab and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90570 Oulu, Finland.
  • Vafeiadi M; Maternal-Fetal Metabolic Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital, 17007 Girona, Spain.
  • Broeren MAC; Pediatric Endocrinology Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital, 17007 Girona, Spain.
  • Palomaki GE; Departament de Ciències Mèdiques, Universitat de Girona, 17003 Girona, Spain.
  • Ashoor G; Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, 81745-33871 Isfahan, Iran.
  • Chen L; Department of Social Medicine, School of Medicine, University of Crete, Heraklion, 710 03 Crete, Greece.
  • Lu X; Laboratory of Clinical Chemistry and Hematology, Máxima Medical Centre, 5504 DB Veldhoven, The Netherlands.
  • Taylor PN; Department of Pathology and Laboratory Medicine, Women & Infants Hospital and Alpert Medical School at Brown University, Providence, RI 02903, USA.
  • Tao FB; Harris Birthright Research Center for Fetal Medicine, King's College Hospital, SE5 9RS London, UK.
  • Brown SJ; Department of Endocrinology and Rui'an Center of the Chinese-American Research Institute for Diabetic Complications, Third Affiliated Hospital of Wenzhou Medical University, 325035 Wenzhou, China.
  • Sitoris G; Department of Endocrinology and Rui'an Center of the Chinese-American Research Institute for Diabetic Complications, Third Affiliated Hospital of Wenzhou Medical University, 325035 Wenzhou, China.
  • Chatzi L; Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, CF10 3EU Cardiff, UK.
  • Vaidya B; Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, 230032 Anhui, China.
  • Popova PV; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei, 230032 Anhui, China.
  • Vasukova EA; Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, 6009 Nedlands, Perth, Australia.
  • Kianpour M; Endocrine Unit, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium.
  • Suvanto E; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
  • Grineva EN; Department of Endocrinology, Royal Devon and Exeter Hospital NHS Foundation Trust, University of Exeter Medical School, EX1 2LU Exeter, UK.
  • Hattersley A; Institute of Endocrinology, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
  • Pop VJM; World-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
  • Nelson SM; Institute of Endocrinology, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
  • Walsh JP; Departament de Ciències Mèdiques, Universitat de Girona, 17003 Girona, Spain.
  • Nicolaides KH; Department of Obstetrics and Gynecology and Medical Research Center Oulu, University of Oulu, 90570 Oulu, Finland.
  • D'Alton ME; Institute of Endocrinology, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
  • Poppe KG; Molecular Medicine, University of Exeter Medical School, Royal Devon & Exeter Hospital, EX3 0AW Exeter, UK.
  • Chaker L; Department of Medical and Clinical Psychology, Tilburg University, 5000 LE Tilburg, The Netherlands.
  • Bliddal S; School of Medicine, University of Glasgow, G12 8QQ Glasgow, UK.
  • Korevaar TIM; Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, 6009 Nedlands, Perth, Australia.
J Clin Endocrinol Metab ; 109(3): 868-878, 2024 Feb 20.
Article en En | MEDLINE | ID: mdl-37740543
ABSTRACT
CONTEXT Guidelines recommend use of population- and trimester-specific thyroid-stimulating hormone (TSH) and free thyroxine (FT4) reference intervals (RIs) in pregnancy. Since these are often unavailable, clinicians frequently rely on alternative diagnostic strategies. We sought to quantify the diagnostic consequences of current recommendations.

METHODS:

We included cohorts participating in the Consortium on Thyroid and Pregnancy. Different approaches were used to define RIs a TSH fixed upper limit of 4.0 mU/L (fixed limit approach), a fixed subtraction from the upper limit for TSH of 0.5 mU/L (subtraction approach) and using nonpregnancy RIs. Outcome measures were sensitivity and false discovery rate (FDR) of women for whom levothyroxine treatment was indicated and those for whom treatment would be considered according to international guidelines.

RESULTS:

The study population comprised 52 496 participants from 18 cohorts. Compared with the use of trimester-specific RIs, alternative approaches had a low sensitivity (0.63-0.82) and high FDR (0.11-0.35) to detect women with a treatment indication or consideration. Sensitivity and FDR to detect a treatment indication in the first trimester were similar between the fixed limit, subtraction, and nonpregnancy approach (0.77-0.11 vs 0.74-0.16 vs 0.60-0.11). The diagnostic performance to detect overt hypothyroidism, isolated hypothyroxinemia, and (sub)clinical hyperthyroidism mainly varied between FT4 RI approaches, while the diagnostic performance to detect subclinical hypothyroidism varied between the applied TSH RI approaches.

CONCLUSION:

Alternative approaches to define RIs for TSH and FT4 in pregnancy result in considerable overdiagnosis and underdiagnosis compared with population- and trimester-specific RIs. Additional strategies need to be explored to optimize identification of thyroid dysfunction during pregnancy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas de Función de la Tiroides / Hipotiroidismo Tipo de estudio: Diagnostic_studies / Guideline / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: J Clin Endocrinol Metab Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas de Función de la Tiroides / Hipotiroidismo Tipo de estudio: Diagnostic_studies / Guideline / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: J Clin Endocrinol Metab Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos
...